Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 9/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | CA12 | O43570 | 2/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.60 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.60 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.58 |
| ▸ | MMP1 | P03956 | 2/20 | 0.55 |
| ▸ | MMP12 | P39900 | 1/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1639878 | 1.00 | KMT2A (1.00) | KMT2AMAPTMEN1TDP1CA12 | |
| Ammonia Solution, Strong SCHEMBL11705203 | 0.98 | KMT2A (0.96) | KMT2AMAPTMEN1TDP1CA12 | |
| SCHEMBL18058690 | 0.96 | KMT2A (0.93) | KMT2AMAPTMEN1TDP1CA12 | |
| Benzoic Acid SCHEMBL9956914 | 0.95 | KMT2A (0.90) | KMT2AMAPTMEN1TDP1CA12 | |
| SCHEMBL16236876 | 0.92 | KMT2A (0.84) | KMT2AMAPTMEN1TDP1CA12 | |
| SCHEMBL16236336 | 0.92 | KMT2A (0.84) | KMT2AMAPTMEN1TDP1CA12 | |
| Betanaphthol SCHEMBL16236859 | 0.92 | KMT2A (0.84) | KMT2AMAPTMEN1TDP1CA12 | |
| SCHEMBL27267181 | 0.91 | KMT2A (0.83) | KMT2AMAPTMEN1TDP1CA12 | |
| SCHEMBL7594572 | 0.89 | KMT2A (0.79) | KMT2AMAPTMEN1TDP1CA12 | |
| SCHEMBL3911876 | 0.88 | KMT2A (0.78) | KMT2AMAPTMEN1TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | disclosed |
| US-12564557-B2 | Dual release dosage form capsule and methods, devices and systems for making same | Gel Cap Technologies, LLC (US) | 2026-03-03 | — | — | US | disclosed |
| CN-113227191-B | Modified epoxy resin, epoxy resin composition, cured product, and laminate for electric/electronic circuit | 三菱化学株式会社 | 2025-01-03 | — | — | CN | disclosed |
| EP-4480495-A2 | DUAL RELEASE DOSAGE FORM CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR MAKING SAME | Gel Cap Technologies, LLC (US) | 2024-12-25 | — | — | EP | disclosed |
| US-20240307315-A1 | DUAL RELEASE DOSAGE FORM CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR MAKING SAME | Gel Cap Technologies, LLC (US) | 2024-09-19 | — | — | US | disclosed |
| EP-3651721-B1 | DUAL RELEASE DOSAGE FORM CAPSULE AND METHODS, DEVICES AND SYSTEMS FOR MAKING SAME | GEL CAP TECH LLC (US) | 2024-09-04 | — | — | EP | disclosed |
| US-11944707-B2 | Dual release dosage form capsule and methods, devices and systems for making same | Gel Cap Technologies, LLC (US) | 2024-04-02 | — | — | US | disclosed |
| CN-116627007-A | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | 富士胶片商业创新有限公司 | 2023-08-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12564557-B2 | Dual release dosage form capsule and methods, devices and systems for making same | CCNA2, PDE1A, MCM2 | KMT2A 3912/4885MAPT 2925/4885MEN1 54/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.